0000950123-19-011059.txt : 20191114 0000950123-19-011059.hdr.sgml : 20191114 20191114083228 ACCESSION NUMBER: 0000950123-19-011059 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 EFFECTIVENESS DATE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Investors, LLC CENTRAL INDEX KEY: 0001703031 IRS NUMBER: 813996001 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18477 FILM NUMBER: 191216548 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162878 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001703031 XXXXXXXX 09-30-2019 09-30-2019 Bain Capital Life Sciences Investors, LLC

200 Clarendon Street Boston MA 02116

13F HOLDINGS REPORT 028-18477 Y Bain Capital Life Sciences Investors, LLC is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of Bain Capital Life Sciences Fund, L.P. The shares of common stock of Dynavax Technologies Corporation ("DVAX") included on the Information Table are as reported on the Schedule 13D filed by Bain Capital Life Sciences Fund, L.P. and BCIP Life Sciences Associates, LP on August 22, 2019 and reflect the exercise and conversion, as applicable, of securities convertible into or exercisable for shares of DVAX common stock held by such persons, after giving effect to the provisions of such securities that prevent the exercise or conversion of such securities if such persons would beneficially own more than 9.99% of the outstanding DVAX common stock following such exercise or conversion. As of September 30, 2019, such persons held 7,525,000 shares of DVAX common stock. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 11-14-2019 2 7 388401 false 1 28-18476 Bain Capital Life Sciences Partners, LP 2 28-18478 Bain Capital Life Sciences Fund, LP INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F DICERNA PHARMACEUTICALS INC COM 253031108 105262 7330237 SH SOLE 7330237 0 0 MARINUS PHARMACEUTICALS INC COM 56854Q101 7766 5042735 SH SOLE 5042735 0 0 REPLIMUNE GROUP INC COM 76029N106 39462 2838968 SH SOLE 2838968 0 0 SOLID BIOSCIENCES INC COM 83422E105 40028 3871164 SH SOLE 3871164 0 0 APTINYX INC COM 03836N103 7766 2225092 SH SOLE 2225092 0 0 SPRINGWORKS THERAPEUTICS INC COM 85205L107 157859 7281307 SH SOLE 7281307 0 0 DYNAVAX TECHNOLOGIES CORP COM 268158201 30259 8452235 SH SOLE 8452235 0 0